Effect of lactulose-derived oligosaccharides on intestinal microbiota during the shift between media with different energy contents by Barroso, Elvira et al.
1 
 
 
Effect of lactulose-derived oligosaccharides on intestinal microbiota 
during the shift between media with different energy contents 
 
Elvira Barroso, Antonia Montilla, Nieves Corzo, Carmen Peláez, M. Carmen 
Martínez-Cuesta, Teresa Requena* 
Instituto de Investigación en Ciencias de la Alimentación, CIAL (CSIC-UAM), CEI 
(UAM+CSIC), Nicolás Cabrera 9, 28049 Madrid, Spain.  
 
*Corresponding author: Tel.: +34 91 0017900; E-mail address: t.requena@csic.es  
 
 
 2 
 
ABSTRACT 1 
The microbiological and metabolic changes of an overweight-associated colonic 2 
microbiota after reducing in vitro the carbohydrate supply and its supplementation with 3 
oligosaccharides derived from lactulose (OsLu) were evaluated using a dynamic 4 
simulator of the gastrointestinal tract. The differentiation and stability of the microbial 5 
communities within each colon compartment were reached after two weeks of feeding 6 
the system with a high energy (HE) medium based on fructose and readily fermentable 7 
starches. The effect of reducing the energy content (low-energy medium, LE) and the 8 
supplementation with OsLu caused minor variations in bacterial counts, except for 9 
Enterobacteriaceace. The LE medium caused an effect on the microbial metabolic 10 
activity that was characterized by an absence of net butyrate production and an increase 11 
in ammonium content. This shift from fermentative to proteolytic metabolism was not 12 
observed when the LE medium was supplemented with OsLu. This oligosaccharide 13 
mixture was mainly metabolized in the proximal colonic compartment. The results 14 
obtained in this study indicate that the substitution in the diet of easily digestible 15 
carbohydrates by OsLu maintains the fermentative functionality of the intestinal 16 
microbiota, allowing the net production of butyric acid with potential beneficial effects 17 
on health, and avoiding a full transition to proteolytic metabolism profiles. 18 
Keywords: prebiotics; OsLu; obesity; diet; gut microbiota; butyric acid 19 
20 
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1. INTRODUCTION 21 
Dietary habits involving high energy intake are related to the development of 22 
overweight and obesity. Monosaccharides and disaccharides such as fructose and sugar 23 
alcohols (sorbitol, lactitol and other polyols), widely used for the formulation of 24 
processed foods or beverages, can reach the large intestine when overfeeding of these 25 
sugars occurs (Payne, Chassard, & Lacroix, 2012). There is epidemiological evidence 26 
that sugar-sweetened beverages increase the risk of overweight and obesity, at all ages, 27 
and that obese individuals are reported to consume significantly more protein and 28 
sugars and lower fibre than normal-weight subjects (Lafontan, Visscher, Farpour-29 
Lambert, & Yumuk, 2015; Requena et al., 2013). Related to it, there is an increased 30 
interest in understanding the possible effects of high energy diets in the intestinal 31 
microbiota. However, the highly personalized human microbiota shows a smaller 32 
dietary influence as the inter-individual variation decreases systematic effects (Wu et 33 
al., 2011; David et al., 2014). Salonen et al. (2014) described that studies from 14 obese 34 
males consuming fully controlled diets supplemented with resistant starch or non-starch 35 
polysaccharides and a weight-loss diet revealed that the diet explained around 10% of 36 
the total variance in microbiota composition, which was substantially less than the inter-37 
individual variance. All these studies have noted strong individuality of the responses, 38 
the extent of which appears to depend on the initial microbiota composition (Korpela et 39 
al., 2014). The fact that the broad phylum level changes between Bacteroidetes and 40 
Firmicutes have not been found consistently (Ley, 2010; Ravussin et al., 2012) may 41 
indicate that relevant changes associated to diet-induced obesity could involve lower 42 
taxonomic levels within these phyla (Cox & Blaser, 2013).  43 
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In view of the fact that prebiotics are well-recognized to influence the gut 44 
microbiota composition, they could be consumed as part of a weight management diet. 45 
Genetically obese mice and diet-induced obese mice and rats (Alligier et al., 2014; 46 
Everard et al., 2011; Pyra, Saha, & Reimer, 2012), as well as overweight and obese 47 
adults (Parnell & Reimer, 2009) have all been reported to exhibit reduced fat mass 48 
following consumption of prebiotics. Indeed, subjects consuming diets rich in fructo-49 
oligosacharides (FOS) and galacto-oligosacharides (GOS) show lower risk of 50 
overweight (Pérez-Cornago et al., 2015). Sarbini, Kolida, Deaville, Gibson, and Rastall 51 
(2014) described the potential of a novel dextran oligosaccharide for obesity 52 
management through in vitro experimentation. The degree of branching of the 53 
compound identified it as a slower-fermenting nutrient that was considered to be 54 
advantageous for obese individuals, as energy would be made available more gradually. 55 
Recently, the enzymatic synthesis of oligosaccharides derived from lactulose (OsLu) 56 
has been aimed for the production of a group of more slowly fermenting prebiotics 57 
(Cardelle-Cobas, Martínez-Villaluenga, Villamiel, Olano, & Corzo, 2008). In addition, 58 
the compounds have demonstrated to be selectively fermented by bifidobacteria and 59 
lactobacilli and to increase the concentration of short chain fatty acids (Cardelle-Cobas 60 
et al., 2012). 61 
In this study we have used the dynamic simulator of the gastrointestinal tract 62 
described by Barroso, Cueva, Peláez, Martínez-Cuesta, and Requena (2015). The model 63 
simulates the gastric and small intestine digestion and is equipped with three-stage 64 
continuous reactors for reproducing the colon region-specific microbiota and its 65 
metabolism. The stabilization period in this study has been adapted to simulate an 66 
obese-associated microbiota by using a high energy-content medium. Changes in 67 
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microbiological and metabolic characteristics were assessed after lowering the energy 68 
content and the supplementation with OsLu used as a potential prebiotic.  69 
2. MATERIALS AND METHODS 70 
2.1. Dynamic simulator of the gastrointestinal tract  71 
The dynamic gastrointestinal simulator SIMGI was used in the operating mode to work 72 
with the units simulating the small intestine (SI) and the ascending (AC), transverse 73 
(TC) and descending colon (DC) regions (Barroso et al., 2015; Fig. S1). Therefore, the 74 
three colon reactors were filled and pre-conditioned with the nutritive medium that feed 75 
the system during the stabilization period. In this case, the setup was made to recreate 76 
an obese-associated microbiota. For this purpose, a starting high energy (HE) medium 77 
was used as described by Payne, Chassard, Banz, and Lacroix (2012), which was 78 
characterized by a high content of high-glycaemic index carbohydrates (digestible 79 
starch) and simple carbohydrates (fructose). The HE medium contained arabinogalactan 80 
(1 g/L), pectin from apple (2 g/L), xylan (1 g/L), potato starch (6 g/L), maize starch (4 81 
g/L), fructose (6 g/L), glucose (0.4 g/L), yeast extract (3 g/L), peptone (1 g/L), mucin (4 82 
g/L) and L-cysteine (0.5 g/L); that is 45% more fermentable carbohydrates than the 83 
standard nutritive medium (Barroso et al., 2015) to create the HE medium. The AC, TC 84 
and DC units were inoculated with 20 mL of a fresh 20% (w/v) faecal sample from an 85 
overweight volunteer, homogenized in anaerobic conditions with sodium phosphate 86 
buffer (0.1 M, pH 7.0), containing 1 g/L sodium thioglycolate as reducing agent, as 87 
described by De Boever, Deplancke, and Verstraete (2000). The development and 88 
stabilization of the microbial community until steady-state conditions in the three colon 89 
units was approached by feeding the small intestine with nutritive medium (75 mL, pH 90 
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2) mixed with pancreatic juice (40 mL of a solution of 12 g/L NaHCO3, 6 g/L oxgall 91 
dehydrated fresh bile and 0.9 g/L porcine pancreatine) three times a day during 14 days 92 
(Van den Abbeele et al., 2010). The small intestine digestion was performed during 2 h 93 
at 37 °C and the content of the vessel was automatically transferred to the following 94 
colon compartment (AC) at a flow rate of 5 mL/min, which simultaneously activated 95 
the transit of colonic content between the AC, TC and DC compartments at the same 96 
flow rate. The overall residence time of the colon compartments was 76 h. All the 97 
vessels were maintained under anaerobic conditions by continuously flushing N2. The 98 
stabilization of the microbial community until steady-state conditions was evaluated by 99 
sampling and measuring the production of short chain fatty acids (SCFA) and 100 
ammonium over time (see below). Stability was reached when rates of change of the 101 
parameters measured dropped below 10% for each colon compartment (Barroso et al., 102 
2015). 103 
After the two-week stabilization period of the colonic microbiota, the SIMGI 104 
was subjected to a 1-week experiment consisting in removing the maize starch and 105 
fructose content and reducing the potato starch content to 1.5 g/L (low energy medium; 106 
LE) and adding 10 g/L of an oligosaccharide mixture derived from lactulose (OsLu), 107 
obtained such as it will be described below. Finally, a 1-week wash-out period was 108 
included at the end of the experiment by feeding the SIMGI daily with the LE medium. 109 
During the whole study, samples were collected daily at regular time points from the 110 
three colon vessels and stored at −20 °C until further analysis. 111 
2.2. Synthesis of oligosaccharides derived from lactulose (OsLu) 112 
OsLu were synthesized following the method described by Anadón et al. (2013) by 113 
using a commercial preparation Duphalac (Abbott Biologicals B.V., Barcelona, Spain), 114 
containing 670 g/L lactulose and the β-galactosidase from Aspergillus oryzae (16 U/mL; 115 
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Sigma-Aldrich, St. Louis, MO, USA). Enzymatic reactions were performed at 50 °C 116 
and pH 6.5 in an orbital shaker at 300 rpm for 24 h. In order to eliminate 117 
monosaccharides, the mixture of oligosaccharides (20%, w/v) was treated with fresh 118 
Saccharomyces cerevisiae (1.5%, w/v) (Levital, Paniberica de Levadura S.A., 119 
Valladolid, Spain) at 30 °C for 48 h in an orbital shaker (300 rpm). Mono- and 120 
disaccharides as well as OsLu were analysed by GC with a flame ionization detector 121 
(GC-FID) as described by Montilla, Van de Lagemaat, Olano, and Del Castillo (2006).  122 
2.3. Microbiological analyses 123 
2.3.1. DNA extraction and purification 124 
Microbial DNA extraction of the samples taken from the AC, TC and DC compartments 125 
was performed as described by Moles et al. (2013). Briefly, samples (1 mL) were 126 
centrifuged (10000×g, 10 min, 4 °C) and the pellet (suspended in 200 mM Tris–HCl pH 127 
7.5, 0.5% SDS, 25 mM EDTA, 250 mM NaCl and 3 M sodium acetate) was incubated 128 
with 20 mg/mL lysozyme and 5 mg/mL lysostaphin (Sigma-Aldrich). Bacterial lysis 129 
was completed by mixing with glass beads. The DNA was extracted with 130 
phenol/chloroform/isoamyl-alcohol, precipitated by adding 0.6 volumes of isopropanol 131 
and finally resuspended in DNase, RNase free water (Sigma-Aldrich). The DNA yield 132 
was measured using a NanoDropH ND-1000 UV spectrophotometer (Nano-Drop 133 
Technologies). 134 
2.3.2. Quantitative PCR (qPCR) 135 
The quantitative microbiological analysis of samples was carried out by qPCR 136 
experiments that were analysed using SYBR green methodology in a ViiA7 Real-Time 137 
PCR System (Life Technologies, Carlsbad, CA, USA). Primers, amplicon size, 138 
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annealing temperature for total bacteria, Bacteroides, Bifidobacterium, 139 
Enterobacteriaceae, Lactobacillus, Prevotella, the specific phylogenetic groups Blautia 140 
coccoides-Eubacterium rectale Cluster XIVa, Ruminococcus Cluster IV and 141 
Clostridium leptum subgroup specific cluster IV have been described previously 142 
(Barroso et al., 2013). DNA from Escherichia coli DH5α, L. plantarum IFPL935, 143 
Bifidobacterium breve 29M2 and Bacteroides fragilis DSM2151 were used for 144 
quantification of total bacteria, Lactobacillus, Bifidobacterium and Bacteroides, 145 
respectively. For the rest of groups analysed, samples were quantified using standards 146 
derived from targeted cloned genes using the pGEM-T cloning vector system kit 147 
(Promega, Madison, WI, USA), as described previously (Barroso et al., 2013). For the 148 
analysis of Akkermansia (primers AM1: CAGCACGTGAAGGTGGGGAC and AM2: 149 
CCTTGCGGTTGGCTTCAGAT), Faecalibacterium (Fprau 07: 150 
CCATGAATTGCCTTCAAAACTGTT and Fprau 02: 151 
GAGCCTCAGCGTCAGTTGGT) and Roseburia (Ros-F1: 152 
GCGGTRCGGCAAGTCTGA and Ros-R1: CCTCCGACACTCTAGTMCGAC), the 153 
samples were quantified using standards derived from clones obtained from the faecal 154 
inoculum, amplified with the mentioned primers and using the conditions described by 155 
Collado, Derrien, Isolauri, De Vos, and Salminen (2007), Sokol et al. (2008), and 156 
Ramirez-Farias et al. (2009), respectively. The PCR amplicons were cloned using the 157 
pGEM-T cloning vector system kit (Promega) as described previously (Barroso et al., 158 
2013). The correctness of the Akkermansia, Roseburia and Faecalibacterium inserts 159 
was confirmed by sequence analysis.   160 
2.3.3. PCR-DGGE 161 
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For evaluation of the microbial community evolution, DNA was amplified using the 162 
universal bacterial primers 968-F and UNI 1401-R described by Nübel et al. (1996). 163 
The primer 968-F was synthesized with a 40-bp GC clamp attached to the 3’ end. Total 164 
volume for PCR reactions was 12.5 µL, composed by 0.75 µL 50 mM MgCl2; 1.25 µL 165 
Taq Buffer 10X; 0.25 µL for each primer (10 µM) and dNTPs (10 mM); 0.125 µL Taq 166 
Polimerase (5 U/µL), about 100 ng of DNA from each sample and filled up to 12.5 µL 167 
with SIGMA water. Amplification protocol was as follows: 94 ºC for 3 min 45 s, 35 168 
cycles of 30 s at 55 ºC (annealing temperature) and 1 min at 72 ºC; and 10 min at 72 ºC. 169 
The PCR products (5 µL) were added in a 0.8% agarose gel and analysed through 170 
DGGE by a DCode system equipment (Bio-Rad Lab., Hercules, CA, USA) using a 9% 171 
polyacrylamide gel and a denaturalizing gradient from 30 to 60% of 7 M urea and 40% 172 
formamide. For electrophoresis assay, it was used TAE buffer 0.5× (20 mM Tris, 10 173 
mM acetic acid and 0.5 mM EDTA), at 70 V and 60 ºC for 16 hours. The DGGE 174 
profiles were digitally normalized by comparison with a home-made standard using 175 
InfoQuest FP software (Bio-Rad). Clustering was performed with Pearson correlation 176 
and the Unweighted Pair Group Method with Arithmetic Mean (UPGMA). 177 
2.4. Microbial metabolism analyses  178 
2.4.1. Short Chain Fatty-Acids (SCFA) determination 179 
Samples from the AC, TC and DC compartments were centrifuged at 13000 ×g for 5 180 
min, the supernatant was filtered and 0.2 µL were injected on a HPLC system (Jasco, 181 
Tokyo, Japan) equipped with a UV-975 detector and automatic injector. SCFA were 182 
separated using a Rezex ROA Organic Acids column (300 × 7.8 mm) (Phenomenex, 183 
Macclesfield, UK) thermostated at 50 °C following the method described by Sanz et al. 184 
(2005). The mobile phase was a linear gradient of 0.005 mM sulphuric acid in HPLC 185 
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grade water, and flow rate was 0.6 mL/min. The elution profile was monitored at 210 186 
nm and peak identification was carried out by comparison between retention times and 187 
standards. For data acquisition and processing it was used a ChromNAV Data System 188 
software (Jasco). Calibration curves of acetic, propionic, butyric, formic and lactic acid 189 
were built up in the range concentration of 1 to 100 mM. 190 
2.4.2. Ammonium determination 191 
Ammonium was determined directly from the supernatant fraction of samples (13000 192 
×g, 15 min, 4 ºC) using an ammonium ion selective electrode (NH500/2; WTW) and 193 
following the manufacturer’s instructions. 194 
2.5. Analysis of carbohydrates 195 
The carbohydrates not metabolized by the microbiota and therefore present in samples 196 
from the AC, TC and DC vessels were determined by GC-FID. Before chromatographic 197 
analysis, samples were centrifuged at 13000×g for 5 min and submitted to a clarification 198 
procedure using Carrez reagents in order to remove interfering compounds (Moreno, 199 
Olano, Santa-María, & Corzo, 1999). The analyses of carbohydrates were performed by 200 
GC-FID (Montilla et al., 2006) as trimethyl silylated oximes (TMSO). Analysis were 201 
carried out in a fused-silica capillary column SGE HT5 (5% phenyl polycarborane-202 
siloxane, 12 m × 0.32 mm × 0.10 µm thickness; SGE Analytical Science, Bellefonte, 203 
USA). The oven temperature was programmed from 150 to 380 °C at a heating rate of 3 204 
°C/min. Injections were made in the split mode (1:10). Data acquisition and integration 205 
were done using the Agilent ChemStations Reb. 4B. 03.01 software (Wilmington, DE, 206 
USA). Quantification of each sugar was performed by internal standard calibration 207 
using phenyl-β-glucoside. Response factors were calculated after the analysis of 208 
standard solutions of fructose, galactose, glucose, lactulose, kestose (trisaccharides) and 209 
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nystose (tetrasaccharides) over the expected concentration range in samples (1-0.01 210 
mg/mL).  211 
3. RESULTS AND DISCUSSION 212 
In addition to non-digestible polysaccharides and resistant starches, which reach the 213 
large intestine undigested due to resistance to human amylase activity (Shimaya et al., 214 
2009), simple sugars and digestible starches, when are consumed abundantly in the diet, 215 
are capable of exceeding intestinal absorption capacity, resulting in high carbohydrate 216 
passage into the large intestine, where they are readily available for gut microbial 217 
fermentation (Payne et al., 2012). Thus, the design of a high energy mediumto simulate 218 
in the SIMGI an obesity-associated microbiota was based on a significant increase in 219 
the content of fructose and readily fermentable starches to the standard nutritious 220 
medium employed to feed the SIMGI colonic reactors (Barroso et al., 2015). This HE 221 
diet design represents the increased prevalence of high consumption of refined 222 
carbohydrates and fructose-saturated sweeteners that is correlating with the global 223 
incidence of obesity (Payne et al., 2012; Charrez, Qiao, & Hebbard. 2015).  224 
3.1. Modulation of bacterial composition 225 
The composition of the microbial community and the bacterial counts reached during 226 
the last three days of each fermentation period (HE, LE-OsLu and LE diets) in the AC, 227 
TC and DC compartments were evaluated by qPCR (Table 1). The end of the 228 
stabilization period with the HE medium was characterized in average by higher counts 229 
in the distal colon regions of Bifidobacterium, Bacteroides, B. coccoides-E. rectale 230 
group, C. leptum, Ruminococcus, Akkermansia, Faecalibacterium, Roseburia and 231 
Enterobacteriacceae. The most noticeable differences in bacterial counts observed in 232 
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the SIMGI when comparing the end of the stabilization period with the HE medium and 233 
the standard medium, which did not contain maize starch and fructose and includes half 234 
content of potato starch (Barroso et al., 2015) were the counts of Bacteroides and, 235 
particularly, Enterobacteriaceae in the three colon compartments that were higher and 236 
lower, respectively, with the HE medium. The increase of Proteobacteria is a common 237 
feature observed in colonic models (Van den Abbeele et al., 2010; Rajilić-Stojanović et 238 
al., 2010). This increase, however, did not take place during the stabilization of the 239 
SIMGI with the HE medium (Table 1). The bacterial genera Akkermansia, 240 
Faecalibacterium and Roseburia were not previously assayed in the SIMGI. The results 241 
indicated a predominance of the three genera in the TC and DC compartments when 242 
compared with the AC. Akkermansia was also found by Van den Abbeele et al. (2010) 243 
in the distal regions of the SHIME. It is important to remark the fact that mucin added 244 
to the nutritive media could be relevant for development of Akkermansia, as these 245 
bacteria depend on mucin as a carbon and nitrogen source (Collado et al., 2007). 246 
Furthermore, A. muciniphila inversely correlates with inflammation and metabolic 247 
disorders associated to obesity (Schneeberger et al., 2015). Faecalibacterium and 248 
Roseburia are butyrate-producing bacteria that have also been described to mitigate 249 
intestinal inflammation (Machiels et al., 2014). B. coccoides-E. rectale were, therefore, 250 
the most representative butyrate producers in the AC compartment (Table 1). The 251 
abundance of this bacterial group in the three colon compartments has also been 252 
described at the end of the stabilization period in the SHIME feed with standard 253 
nutritive medium (Barroso et al., 2014; Van den Abbeele et al., 2010). 254 
After the 15-days stabilization period of the colonic microbiota in the SIMGI 255 
with the HE nutritive medium, a shift in diet was carried out by the suppression in the 256 
medium of simple carbohydrates and the sharp reduction of the content of readily 257 
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fermentable starches (LE medium). The carbohydrate content was replaced with the 258 
oligosaccharide mixture OsLu. Composition of the purified oligosaccharide mixture 259 
contained 76% of sugars, which corresponded to 11% of monosaccharides, 21% 260 
lactulose and 43% of OsLu, and 18% moisture, 5% salts and 1% nitrogen. The feeding 261 
of the SIMGI with OsLu showed no bifidogenic effect when compared with the HE and 262 
LE media. On the other hand, it was observed lower counts of Enterobacteriaceae when 263 
comparing with the feeding with the LE medium (Table 1). Overall, during the feeding 264 
of the SIMGI with the LE-OsLu medium, the highest bacterial counts were recorded for 265 
the TC compartment, including Bifidobacterium, Bacteroides, B. coccoides-E. rectale 266 
group, C. leptum, Faecalibacterium and Roseburia. Lactobacillus was also highly 267 
represented in the AC compartment at the end of the LE-OsLu diet. Most of the 268 
microbial changes observed between the HE and LE-OsLu mediapersisted during the 269 
feeding with the LE medium, except for the increase of Bacteroides and B. coccoides-E. 270 
rectale group (in the AC compartment), and Enterobacteriaceace (in all compartments) 271 
observed at the end of the experimental study with the LE diet (Table 1). However, 272 
except for Enterobacteriaceace, differences in bacterial counts between diets involved 273 
variations generally below 1 log units, indicating that the differences in the amount of 274 
nutrients, including the supply with 10 g/L of the OsLu mixture, were not able to cause 275 
a substantial effect in the bacterial counts such as a relevant shifting between 276 
saccharolytic and proteolytic populations. The prebiotic potential of OsLu, however, 277 
was previously demonstrated through in vitro batch assays using faecal slurries 278 
(Cardelle-Cobas et al., 2012) and in vivo assays using growing rats fed with these 279 
oligosaccharides (Algieri et al., 2014; Hernández-Hernández et al., 2012; Marin-280 
Manzano et al., 2013). The absence of bifidogenic effect during the shift between the 281 
HE and LE-OsLu mediacould be attributed to the high fermentable carbohydrate 282 
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content present in the HE medium which also favoured the growth of these bacteria. As 283 
mentioned above, the microbial effect persisted during feeding with the LE diet. 284 
The qPCR counts were in agreement with the qualitative assessment of bacterial 285 
diversity analysed by PCR-DGGE. The analysis was carried out to compare the 286 
differentiation of microbial communities within each colon compartment and to 287 
qualitatively detect changes to the biodiversity as a function of varied substrate 288 
availability. Fig. 1 shows the microbial community profiles of the AC, TC and DC 289 
compartments at the last day of each intervention period of the SIMGI with the HE 290 
medium followed by the LE medium supplemented with OsLu and finally with only the 291 
LE medium. The results showed that samples from the three colon compartments 292 
clustered together independently of the carbohydrate content of the diets. This feature is 293 
consequence of the characteristics of three-stage fermentation models that allow 294 
reproducing differences from proximal, characterized by acidic pH and carbohydrate-295 
excess conditions, to distal colonic regions showing a carbohydrate-depleted and non-296 
acidic environment (Macfarlane & Macfarlane, 2007).  297 
3.2. Modulation of microbial metabolism  298 
The results of metabolic activity, determined as carbohydrate utilization and production 299 
of SCFA, lactic acid and ammonium, of the microbial community during the last three 300 
days of each fermentation period (HE, LE-OsLu and LE) in the AC, TC and DC 301 
compartments are shown in Fig. 2 and Table 2.  302 
The remaining carbohydrates in effluents from the AC compartment at the end 303 
of the stabilization period with the HE medium and along the feeding period with LE-304 
OsLu and LE media are shown in Fig. 2. Previously, no degradation of oligosaccharides 305 
by pancreatic enzymes in the SI compartment during the daily feeding of the dynamic 306 
simulator with the OsLu mixture was observed (results not shown), supporting the 307 
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indigestible properties of OsLu. Total carbohydrate content was high in the AC 308 
compartment during the feeding with HE and LE-OsLu media and it decreased by 5-6 309 
times with the LE medium (Fig 2). Total carbohydrates content in the TC compartment 310 
was also higher during feeding with HE and LE-OsLu, but values remained around 0.15 311 
mg/mL (results not shown). The level of di- and oligosaccharides increased in the AC 312 
compartment during initial feeding of the simulator with the LE-OsLu mediumand they 313 
decreased thereafter indicating a net degradation of OsLu by the AC microbiota after 314 
two days of diet change adaptation. A great utilization of di- and oligosaccharides by 315 
microorganisms from LE-OsLu diet in the AC compartment was observed and only 316 
small amounts (7-16%) reached the TC. The level of fructose in AC effluents was up to 317 
0.59 mg/mL when HE mediumwas used, indicating its consumption by the intestinal 318 
microbiota as well as the galactose and glucose derived from OsLu hydrolysis during 319 
feeding the LE-OsLu diet (Fig 2). The results of this study were in agreement with those 320 
reported by Macfarlane, Macfarlane and Gibson (1998) during inulin feeding into a 321 
three-stage continuous culture system, since the majority of carbohydrate breakdown 322 
occurred in the vessel simulating the proximal colon. Mäkelainen, Mäkivuokko, 323 
Salminen, Rautonen, and Ouwehand (2007) using a semi-continuous system with four 324 
vessels mimicking the conditions in the human large intestine from proximal to distal 325 
colon, obtained a sustained degradation of polydextrose throughout the gut model and a 326 
rapid xylitol fermentation in the proximal colonic regions.  327 
Regarding formation of microbial metabolites, except for lactic and formic 328 
acids, the SCFA and ammonium concentrations gradually increased from the AC to the 329 
DC compartment because of the accumulation of products in the system, consistent with 330 
operation of three-stage culture reactors without absorption steps (Cinquin, Le Blay, 331 
Fliss, & Lacroix, 2006; Possemiers, Verthe, Uyttendaele, & Verstraete, 2004). Lactic 332 
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and formic acids were only produced in the AC compartment and the latest only with 333 
the HE and LE-OsLu diets. Lactic acid can be further metabolized within the colon and 334 
turned into butyric and propionic acids through cross-feeding by gut bacteria (Duncan, 335 
Louis, & Flint, 2004; Reichardt et al., 2014). Likewise, formic acid is a component in 336 
the mutualistic interaction between fermentative bacteria and syntrophic metabolizers 337 
and has an important role in anaerobic metabolism via interspecies cross-feeding 338 
interactions (Louis, Hold, & Flint, 2014). Bifidobacterium has been described to 339 
produce formic acid from several carbohydrate sources, whereas some Lactobacillus 340 
species undergo a metabolic shift towards acetate and formate production, at the 341 
expense of lactate production, when growing on non-digestible oligosaccharides 342 
(Tabasco, Fontecha, Fernández de Palencia, Peláez, & Requena, 2014). The metabolic 343 
shift has been associated with more ATP production, resulting in a more efficient use of 344 
the available energy source (Van der Meulen, Makras, Verbrugghe, Adriany, & De 345 
Vuyst, 2004). 346 
The effect of reducing the carbohydrate loading on microbial metabolic activity 347 
was characterized by an overall 2-fold decrease in the average content of total SCFA, 348 
mainly associated with acetic acid changes, of the three colon compartments with the 349 
LE diet compared to the HE intake period. Within the SCFA analyzed, propionic acid 350 
production was the least affected by nutrient load, whereas butyric acid production was 351 
practically stopped with the LE diet (Table 2). These results point toward the microbial 352 
utilization of the butyric acid via methanogenesis or sulphate reduction (Worm et al., 353 
2014). The absence of net butyric acid production could be restored by supplementing 354 
the LE medium with OsLu. Additionally, the shift from high to low energy medium 355 
caused a 1.5-fold increase in the ammonium content of the TC compartment and a 356 
remarkable 5.5-fold increase in the proximal colon compartment (AC). This shift from 357 
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fermentative to proteolytic metabolism in the AC was not observed when the LE 358 
medium was supplemented with OsLu (Table 2; Fig. S1). The SFCA and ammonium 359 
results could be compared with in vivo data from obese subjects, where a significant 360 
decrease of SCFA, particularly acetic and butyric acids, and an increase of proteolytic 361 
products were observed when the individuals consumed diets high in protein and 362 
reduced in total carbohydrates (Russell et al., 2011). There is evidence from both 363 
humans and animal models that dietary supplementation with non-digestible 364 
carbohydrates can decrease protein fermentation in the large intestine, which concurs 365 
with a decrease in the genotoxicity of faecal water (Windey, De Preter, & Verbeke, 366 
2012). Likewise, Algieri et al. (2014) observed in colitic rats a significant reduction in 367 
the production of SCFA as a consequence of the colonic inflammatory process that was 368 
restored by feeding the rats with lactulose and OsLu.  369 
4. Conclusions 370 
In conclusion, the results obtained in this study indicate that except for 371 
Enterobacteriaceae, characterized by becoming great competitors in carbohydrate 372 
scarcity, stability of the microbial populations was the dominant pattern. Community 373 
structure clusters were predominately a function of the specific-region colonic 374 
conditions, suggesting that community structures are relatively robust with little 375 
substantial change during shifts in nutrient supply. Furthermore, metagenomic studies 376 
are consistently showing that inter-individual differences in gut microbiota in terms of 377 
microbial composition can be over 90% (Dorrestein, Mazmanian, & Knight R, 2014), 378 
but that there is an assembly of functional communities that share similarities in their 379 
metabolic pathways (Shafquat, Joice, Simmons, & Huttenhower, 2014). It implies that 380 
distinct microbial species may be responsible for specific functions and adapt 381 
themselves to environment and diet affecting human homeostasis and health status. The 382 
 18 
 
results obtained in this study indicate that substitution of easily digestible carbohydrates 383 
by OsLu allows the development of a fermentative functionality, maintaining the net 384 
production of butyric acid with potential beneficial effects on health, and avoiding a full 385 
transition to proteolytic metabolism profiles. 386 
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 609 
Legend to figures 610 
 611 
Fig. 1. Clustering tree of total bacteria DGGE profiles of samples from the ascending 612 
(CA; green), transverse (CT; orange) and descending (CD; fuchsia) colon compartments 613 
at the last 1-2 days of feeding the dynamic simulator of the gastrointestinal tract 614 
(SIMGI) with the HE (red; days 1-14), LE (violet; days 15-21) and LE with OsLu (blue; 615 
days 22-28)) media. 616 
 617 
Figure 2.- Evolution of carbohydrate content (mg/mL) in the ascending colon (AC) 618 
compartment during feeding of the dynamic simulator of the gastrointestinal tract 619 
(SIMGI) with the high energy (HE; days 1-14) medium and the low energy (LE) 620 
medium with (days 15-21) and without (days 22-28) oligosaccharides derived from 621 
lactulose (OsLu). Oligosaccharides: carbohydrates with degree of polymerization ≥ 3. 622 
623 
 26 
 
Table 1. Mean ± SD of quantitative PCR counts (log copy number/ml) for the different 624 
microbial groups analysed in the ascending (AC), transverse (TC) and descending colon 625 
(DC) of the SIMGI at the end of the stabilization period with the high energy (HE; days 626 
1-14) medium and at the end of the feeding with the low energy (LE) medium with 627 
(days 15-21) and without (days 22-28) oligosaccharides derived from lactulose (OsLu). 628 
Bacterial group Compartment          Medium 
  HE LE OsLu LE 
Total bacteria AC 8.83 ± 0.29 8.92 ± 0.42 9.11 ± 0.23 
 TC 9.14 ± 0.23 9.19 ± 0.66 9.45 ± 0.17 
 DC 9.42 ± 0.18 8.87 ± 0.12 9.26 ± 0.10 
Lactobacillus AC 7.36 ± 0.32 7.74 ± 0.38 7.74 ± 0.46 
 TC 7.41 ± 0.08 7.45 ± 0.18 7.49 ± 0.23 
 DC 7.20 ± 0.13 6.83 ± 0.11 6.94 ± 0.33 
Bifidobacterium AC 6.45 ± 1.04 5.22 ± 0.04 5.81 ± 1.58 
 TC 7.30 ± 0.52 7.62 ± 0.48 7.87 ± 0.25 
 DC 7.45 ± 0.16 7.46 ± 0.25 7.92 ± 0.14 
Bacteroides AC 8.66 ± 0.38 9.00 ± 0.33 9.52 ± 0.16 
 TC 9.29 ± 0.13 9.51 ± 0.08 9.51 ± 0.10 
 DC 9.32 ± 0.22 8.98 ± 0.27 9.24 ± 0.12 
Blautia coccoides- AC 7.38 ± 1.00 7.19 ± 0.39 8.05 ± 0.41 
Eubacterium rectale TC 8.50 ± 0.14 8.46 ± 0.11 8.56 ± 0.07 
 DC 8.69 ± 0.18 7.97 ± 0.42 8.16 ± 0.18 
Clostridium leptum AC 2.70 ± 0.77 2.11 ± 0.28 2.28 ± 0.10 
 TC 7.24 ± 0.16 6.92 ± 0.10 6.96 ± 0.09 
 DC 7.00 ± 0.20 6.48 ± 0.24 6.69 ± 0.03 
Ruminococcus AC 1.73 ± 1.23 3.43 ± 1.78 1.94 ± 0.94 
 TC 4.67 ± 0.08 4.85 ± 0.06 5.53 ± 0.36 
 DC 5.51 ± 0.01 5.47 ± 0.20 5.89 ± 0.13 
Prevotella AC 4.16 ± 0.61 4.54 ± 1.20 5.18 ± 0.05 
 TC 4.62 ± 0.46 4.96 ± 0.62 5.56 ± 0.28 
 DC 4.72 ± 0.21 4.46 ± 0.09 4.56 ± 0.01 
Akkermansia AC 2.20 ± 0.79 2.80 ± 0.16 3.18 ± 0.26 
 TC 3.57 ± 0.05 3.52 ± 0.55 3.39 ± 0.41 
 DC 3.46 ± 0.04 3.89 ± 0.57 3.91 ± 0.13 
Roseburia AC 2.68 ± 0.17 2.04 ± 0.14 2.63 ± 0.42 
 TC 8.22 ± 0.05 7.89 ± 0.36 7.84 ± 0.21 
 DC 7.32 ± 0.03 7.23 ± 0.77 7.58 ± 0.28 
Faecalibacterium AC n.d. n.d n.d. 
 TC 6.23 ± 0.01 5.48 ± 0.76 6.06 ± 0.33 
 DC 6.14 ± 0.87 5.11 ± 0.28 6.05 ± 0.12 
Enterobacteriaceae AC 2.84 ± 0.17 5.56 ± 0.28 7.43 ± 0.13 
 TC 6.18 ± 0.03 7.56 ± 0.08 7.75 ± 0.16 
 DC 5.95 ± 0.19 6.72 ± 0.23 7.88 ± 0.16 
nd: not detected  629 
630 
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Table 2. Changes in concentration (mM; mean ± SD) of SCFA and ammonium in the 631 
ascending (AC), transverse (TC) and descending colon (DC) of the SIMGI at the end of 632 
the stabilization period with the high energy (HE) medium (days 1-14) and at the end of 633 
the feeding with the low energy (LE) medium with (days 15-21) and without (days 22-634 
28) oligosaccharides derived from lactulose (OsLu). 635 
Compound  HE LE OsLu LE 
Total SCFA AC 88.24 ± 2.53 59.17 ± 12.36 36.54 ± 0.74 
 TC 110.04± 14.50 94.30± 16.12 50.89± 1.36 
 DC 120.35 ± 2.50 86.88 ± 0.21 54.80 ± 0.21 
Acetic acid AC 45.46 ± 3.79 33.91 ± 2.08 22.81 ± 0.86 
 TC 57.63 ± 6.27 46.43 ± 7.55 30.84 ± 0.33 
 DC 62.84 ± 1.61 44.03 ± 0.44 30.70 ± 0.47 
Propionic acid AC 16.36 ± 0.30 17.27 ± 4.84 11.06 ± 0.14 
 TC 28.05 ± 4.64 25.60 ± 4.94 16.69 ± 1.16 
 DC 32.17 ± 1.32 26.48 ± 0.55 20.55 ± 0.34 
Butyric acid AC 21.39 ± 0.43 13.58 ± 4.29 0.05 ± 0.08 
 TC 27.53 ± 4.24 22.28 ± 3.63 3.36 ± 0.13 
 DC 25.34 ± 0.43 16.38 ± 0.77 3.34 ± 0.62 
Lactic acid AC 3.85 ± 0.00 2.53 ± 0.00 2.62 ± 0.05 
 TC nd nd nd 
 DC nd nd nd 
Formic acid AC 3.12 ± 1.32 2.90 ± 0.00 nd 
 TC nd nd nd 
 DC nd nd nd 
Ammonium AC 4.05± 1.19 7.07± 3.09 22.39± 4.97 
 TC 34.80± 15.79 50.61± 6.44 50.44± 6.99 
 DC 55.68± 19.23 67.50± 5.15 63.10± 2.47 
nd: not detected 636 
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 663 
Fig. S1. Schematic diagram of the dynamic simulator of the intestinal microbiota, 664 
including the small intestine and the ascending (AC), transverse (TC) and descending 665 
colon (DC) compartments. The setup included the feeding with a starting high energy 666 
(HE) medium for 14 days, a 1-week experiment with a low energy (LE) medium with 667 
the oligosaccharide mixture derived from lactulose (OsLu) and a 1-week wash-out 668 
period with the LE medium. 669 
670 
 31 
 
 671 
 672 
Fig. S2. Changes in concentration (mM) of butyric acid (A) and ammonium (B) in the 673 
ascending colon of the SIMGI at the end of the stabilization period with the high energy 674 
(HE; days 1-14) medium and during the feeding with the low energy (LE) medium with 675 
(days 15-21) and without (days 22-28) oligosaccharides derived from lactulose (OsLu). 676 
